Delivery Order SPE2DB20D1100-SPE2DB25FD6E9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,524.73 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for this...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FYCOMPA 8 MG TABLET 30S, a prescription medication. The delivery order has a ceiling value of $1,591.19 and is a firm fixed-price contract. The place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.52 delivery order contract is for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 10 MG TABLET 30S. The contract has a firm fixed price of $3,752.89 and a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- This delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to Amerisourcebergen Drug Corporation for $2,005.44 to supply 4561772725 FYCOMPA 6 MG TABLET 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The firm fixed price contract has a period of performance from August 10, 2023 through August 11, 2023. As the DLA supports the medical supply needs of the Department of Defense, this order is likely providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.80 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 10, 2025 and is not designated with a set-aside. The contract provides for the delivery of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,244.15, is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6E9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Fycompa 8 mg tablets in a quantity of 30 units, with a contract ceiling value of $1,027.44. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver medications and supplies to support military healthcare programs worldwide, with this particular delivery order fulfilling a pharmaceutical requirement for neurological treatment applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/24/25 |